Predictable signs of benign course of polypoidal choroidal vasculopathy: based upon the long-term observation of non-treated eyes

被引:12
|
作者
Okubo, Akiko [1 ]
Arimura, Noboru [1 ]
Abematsu, Noriko [1 ]
Sakamoto, Taiji [1 ]
机构
[1] Kagoshima Univ, Dept Ophthalmol, Grad Sch Med & Dent Sci, Kagoshima 8908520, Japan
关键词
benign; clinical course; polypoidal choroidal vasculopathy; predictable sign; visual prognosis; INTRAVITREAL BEVACIZUMAB AVASTIN; PHOTODYNAMIC THERAPY; MACULAR DEGENERATION;
D O I
10.1111/j.1755-3768.2009.01850.x
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To find predictable signs of benign polypoidal choroidal vasculopathy (PCV). Methods: Medical records of 13 eyes from 12 patients who were followed up for 5 years or longer without treatment among 258 consecutive patients with PCV were reviewed retrospectively. The main outcomes measured were best corrected visual acuity (BCVA) and fundus findings during the follow-up period. Results: The average age at presentation was 68 years, and the average follow-up period after diagnosis was 80 months (range, 62-119 months). The initial mean logarithmic value of the minimal angle of resolution (logMAR) BCVA was 0.28 +/- 0.26, and the final mean logMAR BCVA was 0.62 +/- 0.72. The difference in the logMAR BCVA values between the two points was not statistically significant (p > 0.05). The trend of change from baseline at 2-year follow-up was consistent with those at 5-year follow-up in nine eyes. Fundus findings at the initial examination were classified into two patterns: (i) reddish-orange nodules and detachment of the retinal pigment epithelium with/without detachment of the neurosensory retina (nine eyes); (ii) reddish-orange nodules alone, or nodules and small subretinal haemorrhage (four eyes). In the eyes with the first pattern, clinical course and visual prognosis were variable. An absence of hard exudates could be a sign to maintain a benign clinical course or stable vision with this pattern. The eyes with the second pattern took a benign clinical course with stable vision. Conclusions: There is certainly a group of PCV eyes with a benign prognosis. Considering the huge cost and risk of current therapies, the initial ocular findings could be deciding factors that determine the necessity for further treatment.
引用
收藏
页码:e107 / e114
页数:8
相关论文
共 35 条
  • [31] Long-term Recurrence in Neovascular Age-related Macular Degeneration or Polypoidal Choroidal Vasculopathy without First Year Recurrence
    Tae, Kee Sun
    Kim, Jong Woo
    Kim, Chul Gu
    Lee, Dong Won
    Kim, Jae Hui
    JOURNAL OF THE KOREAN OPHTHALMOLOGICAL SOCIETY, 2018, 59 (10): : 908 - 914
  • [32] Long-term Resolution of Blinding Polypoidal Choroidal Vasculopathy with Recurrent Bilateral Central Involvement by Low-dose Oral Eplerenone Treatment
    Bialasiewicz, Alexander Arthur
    Abdelhamid, Mahmoud
    Shenoy, Radha
    Barman, Manish
    MIDDLE EAST AFRICAN JOURNAL OF OPHTHALMOLOGY, 2016, 23 (02) : 225 - 228
  • [33] Long-Term Outcomes of Switching from Fixed-Dose to As-Needed Regimen for Treating Submacular Hemorrhage Secondary to Polypoidal Choroidal Vasculopathy
    Kim, Jae Hui
    Kim, Jong Woo
    Kim, Chul Gu
    Lee, Dong Won
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (08) : 1 - 10
  • [34] Influence of submacular hemorrhage at baseline on the long-term outcomes of aflibercept treatment for typical neovascular age-related macular degeneration and polypoidal choroidal vasculopathy
    Hosokawa, Mio Morizane
    Ouchi, Chihiro
    Shiode, Yusuke
    Kimura, Shuhei
    Matoba, Ryo
    Morita, Tetsuro
    Morizane, Yuki
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2024, 262 (10) : 3099 - 3107
  • [35] Polypoidal Choroidal Vasculopathy after Stereotactic Radiotherapy for Neovascular Age-Related Macular Degeneration: A Case Report with Long-Term Follow-Up
    Steinemann, Alexandra
    Hoffmann, Laura
    Hatz, Katja B.
    CASE REPORTS IN OPHTHALMOLOGY, 2021, 12 (01): : 299 - 305